Structure Therapeutics (GPCR) 10% owner Fmr sold 26,310 American Depositary Shares for $470K at $17.87
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Fmr Llc (See Remark 1 at Structure Therapeutics Inc., GPCR) reported that they sold 26,310 American Depositary Shares for $470K at $17.87 on Jul 30, 2025.
- Reporting person
- Fmr Llc
- Role
- See Remark 1
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 30, 2025 | Open-market sale (S) | American Depositary SharesOn 78,930 Ordinary Shares1 | -26,310 | $17.87 | $470K | 1,515,558 indirect |
Holdings before and after
- American Depositary Shares: 1,541,868 to 1,515,558 indirect, Shares held by persons and entities whose shares are subject to reporting by the undersigned
Other positions listed
- Ordinary Shares: 45,120 indirect, F-Prime Capital Partners Life Sciences Advisors Fund VI LP
- Ordinary Shares: 530,814 indirect, F-Prime Capital Partners Life Sciences Fund VI LP
Footnotes from the filing
- 1. Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Fmr report in this GPCR Form 4?
Fmr Llc (See Remark 1 at Structure Therapeutics Inc., GPCR) reported that they sold 26,310 American Depositary Shares for $470K at $17.87 on Jul 30, 2025.
Was this GPCR insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for GPCR
Earlier insider filings at GPCR
- Jul 3, 2025CHIEF TECHNOLOGY OFFICER Ma Yingli covered exercise/tax liability with 1,824 units of Ordinary Shares and was granted 24,459 units of Ordinary Shares, increasing direct ownership by 23% to 123,174 units (SEC Form 4)
- Jul 3, 2025CHIEF MEDICAL OFFICER Coll Crespo Blas was granted 7,992 units of Ordinary Shares and covered exercise/tax liability with 2,667 units of Ordinary Shares, increasing direct ownership by 2% to 224,913 units (SEC Form 4)
- Jul 3, 2025CHIEF SCIENTIFIC OFFICER Lin Xichen covered exercise/tax liability with 6,441 units of Ordinary Shares and was granted 57,078 units of Ordinary Shares, increasing direct ownership by 30% to 217,173 units (SEC Form 4)
- Jul 3, 2025CHIEF FINANCIAL OFFICER Yoon Jun covered exercise/tax liability with 13,029 units of Ordinary Shares and was granted 39,606 units of Ordinary Shares, increasing direct ownership by 2% to 1,319,876 units (SEC Form 4)
- Jul 3, 2025CHIEF EXECUTIVE OFFICER Stevens Raymond C covered exercise/tax liability with 28,545 units of Ordinary Shares and was granted 89,697 units of Ordinary Shares, increasing direct ownership by 5% to 1,194,830 units (SEC Form 4)
Quantisnow market dataNASDAQ
GPCR
Structure Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2023
Get push alerts for GPCR
Full GPCR profile on Quantisnow Follow GPCR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time